A Digital App to Help Patients with Acute Myeloid Leukemia
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia
This project explores if a new digital app can help patients with acute myeloid leukemia feel better and improve their well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11141650 on NIH RePORTER |
What this research studies
When you're diagnosed with acute myeloid leukemia (AML), it's a sudden and serious event that requires immediate hospitalization for chemotherapy. This time can be very challenging, with difficult physical symptoms and immense emotional distress due to the shock of diagnosis, uncertainty, and isolation. Since there aren't many ways to support patients during this tough period, researchers created a new digital app called DREAMLAND. This app offers supportive guidance and education to help patients cope with their diagnosis and manage their well-being while undergoing treatment.
Who could benefit from this research
Good fit: This opportunity is for patients newly diagnosed with acute myeloid leukemia who are about to start intensive chemotherapy and are hospitalized for treatment.
Not a fit: Patients who are not newly diagnosed with acute myeloid leukemia or are not undergoing intensive chemotherapy may not find this app relevant to their current situation.
Why it matters
Potential benefit: If successful, this app could provide much-needed emotional support and improve the quality of life for patients undergoing intensive chemotherapy for acute myeloid leukemia.
How similar studies have performed: This project involves a newly developed digital application, suggesting a novel approach to providing supportive care for AML patients.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: El-Jawahri, Areej — Massachusetts General Hospital
- Study coordinator: El-Jawahri, Areej
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.